Naproxen and Optimark drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Naproxen (naproxen) and Optimark (gadoversetamide). Common drug interactions include ocular icterus among females and mobility decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Naproxen and Optimark. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Naproxen?
Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,034 Naproxen users. Check the latest studies of Naproxen.
What is Optimark?
Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
15 people who take Naproxen and Optimark together, and have interactions are studied.

What are the common drug interactions of Naproxen and Optimark, by gender? *:
female:
- Ocular icterus (presence of jaundice seen in the sclera of the eye)
- Pruritus (severe itching of the skin)
- Purpura (purplish discoloration of the skin)
- Rash
- Rash macular (small, flat red spots)
- Rash papular (redness with papule)
- Scar
- Skin burning sensation
- Skin discolouration (change of skin colour)
- Skin fibrosis (fibrous tissue formation on skin)
male:
- Mobility decreased (ability to move is reduced)
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Hypoaesthesia (reduced sense of touch or sensation)
- Pain in extremity
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Peripheral coldness
- Skin exfoliation (removal of the oldest dead skin cells)
- Skin fissures (a crack in the skin)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin lesion
What are the common drug interactions of Naproxen and Optimark, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Osteoporosis (bones weak and more likely to break)
- Overdose
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Renal failure chronic (long lasting kidney dysfunction)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Thrombocytopenia (decrease of platelets in blood)
- Urinary tract infection
- Vision blurred
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
50-59:
n/a
60+:
- Mobility decreased (ability to move is reduced)
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Muscular weakness (muscle weakness)
- Pain in extremity
- Pruritus (severe itching of the skin)
- Scar
- Skin burning sensation
- Skin induration (an abnormally hard spot or area on the skin)
- Pain of skin
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
What are the existing conditions these people have? *
- Nuclear Magnetic Resonance Imaging Brain: 12 people, 80.00%
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 6 people, 40.00%
- Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 20.00%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 20.00%
- High Blood Pressure: 3 people, 20.00%
- High Blood Cholesterol: 3 people, 20.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 20.00%
- Anaemia (lack of blood): 3 people, 20.00%
- Renal Mass (mass in kidney): 2 people, 13.33%
- Renal Abscess (pus in kidney): 2 people, 13.33%
* Approximation only. Some reports may have incomplete information.
Do you take Naproxen and Optimark?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Naproxen and Optimark:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Naproxen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Optimark:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Naproxen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Optimark and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on naproxen and gadoversetamide (the active ingredients of Naproxen and Optimark, respectively), and Naproxen and Optimark (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Chromic Chloride cause Balance Disorder? - 2 seconds ago
- Could Valproic Acid cause Anticonvulsant Drug Level Abnormal? - 4 seconds ago
- Drug interactions of Colcrys and Ventavis - 6 seconds ago
- Could Gammagard cause Eye Pain? - 6 seconds ago
- Could Pulmicort cause Hip Joint Replacement? - 8 seconds ago
- Could Pulmicort cause Bladder Neoplasm? - 9 seconds ago
- Could Pulmicort Flexhaler cause Nasopharyngitis? - 9 seconds ago
- Drug interactions of Indomethacin Sodium and Profen - 11 seconds ago
- Could Metformin cause Pneumonia Staphylococcal? - 11 seconds ago
- Could Gabapentin cause Circadian Rhythm Sleep Disorder? - 15 seconds ago